Search results
‘Oppenheimer’ Among Movies Coming To Streaming On Prime Video In June
Forbes· 5 days agoChristopher Nolan’s “Oppenheimer” and eight "Godzilla" movies are among the June streaming titles...
Robert Downey Jr. Reveals He's 'Surprisingly Open' for MCU Return
Epicstream.com· 7 hours agoRobert Downey Jr. recently admitted that he's been "surprisingly open" with the idea of making his...
Oppenheimer Cinematographer Clashes with Netflix CEO on Movie Screen Size
PetaPixel· 1 day agoAfter Netflix CEO Ted Sarandos claimed that both Barbie and Oppenheimer would have done just as well...
Author Le Ly Hayslip and ‘Oppenheimer’ Producer Thomas Hayslip Explore Vietnam Women in Documentary...
Variety via Yahoo News· 1 day agoFilm producers Le Ly Hayslip (“Heaven & Earth”) and son Thomas Hayslip (“Oppenheimer,” “Ferrari”)...
10 Movies We’re Excited to See at Tribeca Festival
Variety via Yahoo News· 3 hours agoTribeca Festival co-founder Jane Rosenthal doesn’t follow a North Star as she and her team sift through tens of thousands of submissions each year. But...
Robert Downey Jr. Says He's 'Surprisingly Open-Minded' About Returning as Iron Man Despite...
People via Yahoo News· 2 hours agoOf himself and Foster, 61, the actor added, "Between Nyad and [True Detective: Night Country] and,...
Iron Man: Robert Downey Jr. Remains ‘Open-Minded’ to MCU Return
SuperHeroHype via Yahoo News· 2 hours agoIron Man may live again in the Marvel Cinematic Universe if Robert Downey Jr. gets his way. During...
...School’s Vice Dean Akira Mizuta Lippit On Reaction To ‘Oppenheimer’ In Japan & How Release...
Deadline Hollywood· 6 days agoEditor’s note: When Christopher Nolan’s eventual Best Picture Oscar winner Oppenheimer began its...
Corbus Pharmaceuticals shares rally on raised price target, Outperform rating By Investing.com
Investing.com· 1 day agoOppenheimer has raised the price target on Corbus Pharmaceuticals (NASDAQ:CRBP) shares to $80 from...
Biomea Fusion (NASDAQ:BMEA) Price Target Cut to $60.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 4 days agoBiomea Fusion (NASDAQ:BMEA – Free Report) had its price objective lowered by Oppenheimer from $70.00 to $60.00 in a report published on Thursday morning, Benzinga reports.